Surgical Instrument Developer Innovex Medical Lands Millions of Dollars In The Newest Round of Financing

According to 36KR, minimally invasive surgical instrument developer Innovex Medical just received millions of dollars in the newest round of financing. This round of financing was led by Zhenghe Huitong Fund, and the funds will be used for R&D and registration for Innovex Medical’s products.

Innovex Medical was founded in 2009, it mainly focused on the development and sales of high-value materials related to digestive endoscopy and urology. Its products include urinary series products, digestive series products, endoscope series products and more. These products can be used in urological surgery, endoscopic retrograde cholangiopancreatography (ERCP), gynecological disease examination, endoscopic diagnosis and treatment, anesthesia applications, and surgeries.

Till this day, Innovex Medical has obtained CFDA registration certificates for 10 of its products in the field of urology. Including sealing stone catheter, non-vascular lumen guide wire, sealing and intercepting catheter II, ureteral dilatation balloon catheter, urinary stone basket and more.

At this moment, Innovex Medical has more than 200 partners, all of which are medical device operators. Innovex Medical is also trying to expand overseas, especially in Europe and North America.  As for the market prospects, the market share of medical devices in China has been rising, especially for high-value materials and endoscopes. The potential profits are enormous

Zhenghe Huitong Fund is a Chinese investment company, its main business includes equity investment, M&A funds, Maxima Fund and S-type funds.